We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Biorepository Facility Offers Wide Range of Storage Options

By LabMedica International staff writers
Posted on 06 Jun 2011
A provider of comprehensive sample management solutions has opened its new state-of-the-art biorepository facility in Indianapolis (IN, USA).

The 60,000-square-foot facility is part of the company's strategic growth plan, and represents a US$4.6 million investment by BioStorage Technologies (Zionsville, IN, USA).

The new biorepository facility offers a wide range of storage options, including automated carousel controlled-room temperature storage at 15 °C to 27 °C, bulk sample storage at 15 °C to 27 °C, walk-in cold sample storage -20 °C to 5 °C, ultra-low temperature storage -70 °C to -80 °C, and -190 °C vapor phase liquid nitrogen.

The biorepository facility is strategically placed near the second largest FedEx hub in the United States. More...
It is dedicated to the preparation, storage, and cold-chain transport of human biological samples for a wide variety of customers, including donor programs, academic centers, contract research organizations, and biotechnology companies.

Once samples are processed, aliquots of blood and/or DNA products can be retrieved and scheduled for transport through the company's proprietary tracking and inventory management system, ISISS. This process ensures samples are removed, transported, processed, and replaced to storage in a compliant, consistent, and efficient fashion.

"The future of drug discovery is in personalized medicine and genomic-based therapies, which will require an ability to store and analyze large quantities of tissue and blood samples," said Greg Swanberg, CEO of BioStorage Technologies. "As this trend continues, an increasing amount of pharma and biotech companies rely on our expertise in comprehensive sample management to ensure their valuable biological samples are managed in optimal conditions and not jeopardized by preanalytical variables that can have a negative impact on sample integrity."

Related Links:

BioStorage Technologies




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hematology Consumables
Bioblood Devices
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.